
Joe Peissel
Lead macroeconomic analyst at Trivium China who provides analysis on China's economic data, policy drivers, and outlook, specializing in macro and market implications.
Top 3 podcasts with Joe Peissel
Ranked by the Snipd community

44 snips
Dec 26, 2025 • 28min
Ep 52 - China's economic slowdown – not as bad as it seems
Joe Peissel, lead macroeconomic analyst at Trivium China, joins to unpack China's recent economic data, revealing a nuanced picture behind the headlines. They discuss the slowdown in fixed asset investment and industrial output, attributing some of it to policy decisions. Despite disappointing retail sales, consumer dynamics show resilience, particularly in services. Peissel also highlights a rebound in exports and a shift toward high-value goods. Looking ahead, they anticipate targeted fiscal measures and continued infrastructure spending as part of China's recovery strategy.

9 snips
Nov 21, 2025 • 51min
Ep 48 - How Xi Jinping thinks about the rule of law + explaining why capital investment is tanking
In a deep dive, Joe Peissel, Head of China macroeconomic research at Trivium, sheds light on China's alarming drop in fixed asset investment and what it means for the economy heading into 2026. He reveals that a 23% plunge in real estate investment is significantly dragging down overall figures. The discussion touches on local governments diverting infrastructure funds, reshaping the landscape of economic growth. Joe also navigates the complexities of China's rule by law and its implications for governance and investment strategies.

Oct 24, 2025 • 1h 13min
Ep 44 - Xi’s make or break moment + USCBC’s Sean Stein on US-China volatility
Joe Peissel, Lead Macroeconomic Analyst at Trivium China, shares insights on China’s fragile consumer confidence despite a GDP growth of 4.8%. He discusses the impacts of uneven recovery and declining housing markets on consumption. Sean Stein, President of the USCBC, navigates the complexities of U.S.-China business relationships amid volatility. He highlights how the fentanyl issue can foster trust and why firms still value the China market for its speed and innovation, even amidst regulatory challenges.


